Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and intense pulsed light effectively reduce unwanted facial hair in women, but may not be cost-effective.

Ficus carica extract improved fertility in rats and may help with certain health conditions.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Lugol's solution can cause thyroid problems if used long-term for non-approved reasons.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

Woodhouse-Sakati syndrome can cause writer's cramp and other varied symptoms, highlighting the importance of genetic testing for diagnosis.

Neuroactive steroids may affect the risk and treatment of alcohol use disorders.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

New compounds may help treat prostate cancer by reducing cell growth.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Most women with Polycystic Ovarian Disease have trouble getting pregnant due to hormonal imbalances, but lifestyle changes and certain drugs can help.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Hair transplantation is highly effective with careful technique and attention to patient needs.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.